The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Alnylam Pharmaceuticals Inc shares valued at $309,527 were sold by Greenstreet Yvonne on Feb 14 ’25. At $255.17 per share, Greenstreet Yvonne sold 1,213 shares. The insider’s holdings dropped to 81,526 shares worth approximately $19.33 million following the completion of this transaction.
Also, Poulton Jeffrey V. sold 967 shares, netting a total of over 246,750 in proceeds. Following the sale of shares at $255.17 each, the insider now holds 32,786 shares.
Before that, Fitzgerald Kevin Joseph had sold 1,440 shares from its account. In a trade valued at $362,243, the CSO & EVP, Head of Research traded Alnylam Pharmaceuticals Inc shares for $251.56 each. Upon closing the transaction, the insider’s holdings decreased to 1,440 shares, worth approximately $3.05 million.
As published in a research note from Wolfe Research on November 12, 2024, Alnylam Pharmaceuticals Inc [ALNY] has been rated down from a Peer perform to an Underperform. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid October. As of August 16, 2024, Goldman has increased its “Neutral” rating to a “Buy” for ALNY. Earlier on February 16, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for ALNY stock which previously was a “a Buy”.
Analyzing ALNY Stock Performance
During the last five days, there has been a drop of approximately -5.54%. Over the course of the year, Alnylam Pharmaceuticals Inc shares have jumped approximately 0.76%. Shares of the company reached a 52-week high of $287.22 on 01/27/25 and a 52-week low of $231.00 on 01/06/25. A 50-day SMA is recorded $254.09, while a 200-day SMA reached $244.60. Nevertheless, trading volume fell to 1.12 million shares from 0.69 million shares the previous day.
Support And Resistance Levels for Alnylam Pharmaceuticals Inc (ALNY)
According to the 24-hour chart, there is a support level at 233.64, which, if violated, would cause prices to drop to 230.18. In the upper region, resistance lies at 243.47. The next price resistance is at 249.84. RSI (Relative Strength Index) is 29.67 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -13.93, which suggests the price will decrease in the coming days. Percent R is at 98.67%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
